JENNIFER JARESS: Open Payments
NPI 1558965004 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 10 payments from 7 companies in 2025. Trend: 2023 $214 · 2024 $634 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $78 |
| Legend Biotech USA Inc. | 2 | $54 |
| Melinta Therapeutics, LLC | 1 | $25 |
| Syndax Pharmaceuticals, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $23 |
| TerSera Therapeutics LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: CARVYKTI, Rezzayo, JAKAFI, Zoladex, PREVYMIS.
Industry payments across MD — which companies pay providers there.
